+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Switzerland Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update

  • PDF Icon

    Report

  • 50 Pages
  • March 2025
  • Region: Switzerland
  • BioIntel360
  • ID: 6067414
Description Jump to:
The diabetes market in Switzerland is expected to grow by 10.9% on annual basis to reach US$1.16 billion in 2025.

The diabetes market in the country has experienced robust growth during 2020-2024, achieving a CAGR of 11.8%. This upward trajectory is expected to continue, with the market forecast to grow at a CAGR of 9.2% during 2025-2029. By the end of 2029, the diabetes market is projected to expand from its 2024 value of USD 1.04 billion to approximately USD 1.82 billion.

This report provides a detailed data-centric analysis of the diabetes industry in Switzerland, covering market opportunities and analysis across a range of diagnosis and monitoring devices, therapeutics, domains. With over 50+ KPIs at the country level, this report provides a comprehensive understanding of diabetes market dynamics, market size and forecast, and market share statistics.

The research methodology is based on industry best practices. Its unbiased analysis leverages a proprietary analytics platform to offer a detailed view of emerging business and investment market opportunities.ScopeThis report provides an in-depth, data-centric analysis of the Latin America diabetes devices and therapeutics market 2020-2029. Below is a summary of key market segments:

Diabetes Devices and Therapeutics Market Share by Category

  • Diagnosis and Monitoring Devices
  • Therapeutics

Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices

  • Blood Glucose Monitoring Devices
  • Insulin Delivery Devices
  • Diabetes Management and Mobile Applications
  • Artificial Pancreas Devices

Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices

  • Self-Monitoring Blood Glucose Devices
  • Continuous Blood Glucose Monitoring Devices
  • Test Strips
  • Lancets

Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices

  • Insulin Pumps
  • Insulin Pens
  • Insulin Syringes

Diabetes Devices and Therapeutics Market Share by Therapeutics

  • Oral Anti-Diabetic Drugs
  • Insulin
  • Non-Insulin Injectable Drugs
  • Combination Drugs

Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs

  • Alpha-Glucosidase Inhibitors
  • DPP-4 Inhibitors
  • SGLT-2 Inhibitors

Diabetes Devices and Therapeutics Market Share by Insulin

  • Basal or Long-Acting
  • Bolus or Fast-Acting
  • Traditional Human Insulin Drugs
  • Insulin Biosimilars

Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs

  • GLP-1 Receptor Agonists
  • Amylin Analogue

Diabetes Devices and Therapeutics Market Share by Combination Drugs

  • Combination Insulin
  • Oral Combination

Diabetes Devices and Therapeutics Market Share by Route of Administration

  • Subcutaneous
  • Intravenous
  • Others

Diabetes Devices and Therapeutics Market Share by Type of Diabetes

  • Type 1 Diabetes
  • Type 2 Diabetes

Diabetes Devices and Therapeutics Market Share by Distribution Channels

  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies

Diabetes Devices and Therapeutics Market Share by End User

  • Hospitals
  • Diabetes Clinics
  • Homecare

Reasons to buy

  • Comprehensive understanding of market structure and dynamics: Gain a detailed view of the diabetes devices and therapeutics market, including category-level segmentation (Diagnosis & Monitoring Devices and Therapeutics) and sub-segmentation by product type, route of administration, type of diabetes, distribution channel, and end user.
  • Identify high-growth segments and strategic investment areas: Use segment-wise market sizing and forecasting to identify opportunities in areas such as continuous glucose monitoring, insulin delivery technologies, oral anti-diabetic drugs, and biosimilars. Tailor your market entry or expansion strategies accordingly.
  • Benchmark performance across distribution and care settings: Access share analysis across online, hospital, and retail pharmacies, and evaluate usage patterns across hospitals, diabetes clinics, and homecare to support channel-specific planning and resource allocation.

Table of Contents

1 Switzerland Diabetes Devices and Therapeutics Market Size and Forecast, 2020-2029
2 Switzerland Diabetes Devices and Therapeutics Market Share by Category, 2020-2029
2.1 Switzerland Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, 2020-2029
2.2 Switzerland Diabetes Devices and Therapeutics Market Size by Therapeutics, 2020-2029
3 Switzerland Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices, 2020-2029
3.1 Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, 2020-2029
3.2 Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, 2020-2029
3.3 Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, 2020-2029
3.4 Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, 2020-2029
4 Switzerland Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices, 2020-2029
4.1 Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, 2020-2029
4.2 Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, 2020-2029
4.3 Diabetes Devices and Therapeutics Market Size by Test Strips, 2020-2029
4.4 Diabetes Devices and Therapeutics Market Size by Lancets, 2020-2029
5 Switzerland Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices, 2020-2029
5.1 Diabetes Devices and Therapeutics Market Size by Insulin Pumps, 2020-2029
5.2 Diabetes Devices and Therapeutics Market Size by Insulin Pens, 2020-2029
5.3 Diabetes Devices and Therapeutics Market Size by Insulin Syringes, 2020-2029
6 Switzerland Diabetes Devices and Therapeutics Market Share by Therapeutics, 2020-2029
6.1 Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, 2020-2029
6.2 Diabetes Devices and Therapeutics Market Size by Insulin, 2020-2029
6.3 Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, 2020-2029
6.4 Diabetes Devices and Therapeutics Market Size by Combination Drugs, 2020-2029
7 Switzerland Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs, 2020-2029
7.1 Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors, 2020-2029
7.2 Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors, 2020-2029
7.3 Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors, 2020-2029
8 Switzerland Diabetes Devices and Therapeutics Market Share by Insulin, 2020-2029
8.1 Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, 2020-2029
8.2 Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, 2020-2029
8.3 Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, 2020-2029
8.4 Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, 2020-2029
9 Switzerland Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs, 2020-2029
9.1 Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, 2020-2029
9.2 Diabetes Devices and Therapeutics Market Size by Amylin Analogue, 2020-2029
10 Switzerland Diabetes Devices and Therapeutics Market Share by Combination Drugs, 2020-2029
10.1 Diabetes Devices and Therapeutics Market Size by Combination Insulin, 2020-2029
10.2 Diabetes Devices and Therapeutics Market Size by Oral Combination, 2020-2029
11 Switzerland Diabetes Devices and Therapeutics Market Share by Route of Administration, 2020-2029
11.1 Diabetes Devices and Therapeutics Market Size by Subcutaneous, 2020-2029
11.2 Diabetes Devices and Therapeutics Market Size by Intravenous, 2020-2029
11.3 Diabetes Devices and Therapeutics Market Size by Others, 2020-2029
12 Switzerland Diabetes Devices and Therapeutics Market Share by Type of Diabetes, 2020-2029
12.1 Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, 2020-2029
12.2 Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, 2020-2029
13 Switzerland Diabetes Devices and Therapeutics Market Share by Distribution Channels, 2020-2029
13.1 Diabetes Devices and Therapeutics Market Size by Online Pharmacies, 2020-2029
13.2 Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, 2020-2029
13.3 Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, 2020-2029
14 Switzerland Diabetes Devices and Therapeutics Market Share by End User, 2020-2029
14.1 Diabetes Devices and Therapeutics Market Size by Hospitals, 2020-2029
14.2 Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, 2020-2029
14.3 Diabetes Devices and Therapeutics Market Size by Homecare, 2020-2029
List of Tables
Table 1: Switzerland Diabetes Devices and Therapeutics Market Size by Value (US$ Million) 2020-2029
Table 2: Switzerland Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (US$ Million), 2020-2029
Table 3: Switzerland Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (US$ Million) 2020-2029
Table 4: Switzerland Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Table 5: Switzerland Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, by Value (US$ Million) 2020-2029
Table 6: Switzerland Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (US$ Million) 2020-2029
Table 7: Switzerland Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, by Value (US$ Million) 2020-2029
Table 8: Switzerland Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (US$ Million) 2020-2029
Table 9: Switzerland Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Table 10: Switzerland Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (US$ Million) 2020-2029
Table 11: Switzerland Diabetes Devices and Therapeutics Market Size by Lancets, by Value (US$ Million) 2020-2029
Table 12: Switzerland Diabetes Devices and Therapeutics Market Size by Insulin Pumps, by Value (US$ Million) 2020-2029
Table 13: Switzerland Diabetes Devices and Therapeutics Market Size by Insulin Pens, by Value (US$ Million) 2020-2029
Table 14: Switzerland Diabetes Devices and Therapeutics Market Size by Insulin Syringes, by Value (US$ Million) 2020-2029
Table 15: Switzerland Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (US$ Million), 2020-2029
Table 16: Switzerland Diabetes Devices and Therapeutics Market Size by Insulin, by Value (US$ Million), 2020-2029
Table 17: Switzerland Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (US$ Million), 2020-2029
Table 18: Switzerland Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (US$ Million), 2020-2029
Table 19: Switzerland Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (US$ Million), 2020-2029
Table 20: Switzerland Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (US$ Million), 2020-2029
Table 21: Switzerland Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (US$ Million), 2020-2029
Table 22: Switzerland Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (US$ Million), 2020-2029
Table 23: Switzerland Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (US$ Million), 2020-2029
Table 24: Switzerland Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (US$ Million), 2020-2029
Table 25: Switzerland Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (US$ Million), 2020-2029
Table 26: Switzerland Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (US$ Million), 2020-2029
Table 27: Switzerland Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (US$ Million), 2020-2029
Table 28: Switzerland Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (US$ Million), 2020-2029
Table 29: Switzerland Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (US$ Million), 2020-2029
Table 30: Switzerland Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (US$ Million), 2020-2029
Table 31: Switzerland Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (US$ Million), 2020-2029
Table 32: Switzerland Diabetes Devices and Therapeutics Market Size by Others, by Value (US$ Million), 2020-2029
Table 33: Switzerland Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (US$ Million), 2020-2029
Table 34: Switzerland Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (US$ Million), 2020-2029
Table 35: Switzerland Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (US$ Million), 2020-2029
Table 36: Switzerland Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (US$ Million), 2020-2029
Table 37: Switzerland Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (US$ Million), 2020-2029
Table 38: Switzerland Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (US$ Million), 2020-2029
Table 39: Switzerland Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (US$ Million), 2020-2029
Table 40: Switzerland Diabetes Devices and Therapeutics Market Size by Homecare, by Value (US$ Million), 2020-2029
List of Figures
Figure 1: Switzerland Diabetes Devices and Therapeutics Market Size by Value (US$ Million) 2020-2029
Figure 2: Switzerland Diabetes Devices and Therapeutics Market Share by Category (%), 2020-2029
Figure 3: Switzerland Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (US$ Million), 2020-2029
Figure 4: Switzerland Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (US$ Million) 2020-2029
Figure 5: Switzerland Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices (%), 2020-2029
Figure 6: Switzerland Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Figure 7: Switzerland Diabetes Devices and Therapeutics Market Size, by Insulin Delivery Devices, by Value (US$ Million) 2020-2029
Figure 8: Switzerland Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (US$ Million) 2020-2029
Figure 9: Switzerland Diabetes Devices and Therapeutics Market Size, by Artificial Pancreas Devices, by Value (US$ Million) 2020-2029
Figure 10: Switzerland Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices (%), 2020-2029
Figure 11: Switzerland Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (US$ Million) 2020-2029
Figure 12: Switzerland Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Figure 13: Switzerland Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (US$ Million) 2020-2029
Figure 14: Switzerland Diabetes Devices and Therapeutics Market Size by Lancets, by Value (US$ Million) 2020-2029
Figure 15: Switzerland Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices (%), 2020-2029
Figure 16: Switzerland Diabetes Devices and Therapeutics Market Share by Insulin Pumps, by Value (US$ Million) 2020-2029
Figure 17: Switzerland Diabetes Devices and Therapeutics Market Share by Insulin Pens, by Value (US$ Million) 2020-2029
Figure 18: Switzerland Diabetes Devices and Therapeutics Market Share by Insulin Syringes, by Value (US$ Million) 2020-2029
Figure 19: Switzerland Diabetes Devices and Therapeutics Market Share by Therapeutics (%), 2020-2029
Figure 20: Switzerland Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (US$ Million), 2020-2029
Figure 21: Switzerland Diabetes Devices and Therapeutics Market Size by Insulin, by Value (US$ Million), 2020-2029
Figure 22: Switzerland Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (US$ Million), 2020-2029
Figure 23: Switzerland Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (US$ Million), 2020-2029
Figure 24: Switzerland Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs (%), 2020-2029
Figure 25: Switzerland Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (US$ Million), 2020-2029
Figure 26: Switzerland Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (US$ Million), 2020-2029
Figure 27: Switzerland Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (US$ Million), 2020-2029
Figure 28: Switzerland Diabetes Devices and Therapeutics Market Share by Insulin (%), 2020-2029
Figure 29: Switzerland Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (US$ Million), 2020-2029
Figure 30: Switzerland Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (US$ Million), 2020-2029
Figure 31: Switzerland Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (US$ Million), 2020-2029
Figure 32: Switzerland Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (US$ Million), 2020-2029
Figure 33: Switzerland Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs (%), 2020-2029
Figure 34: Switzerland Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (US$ Million), 2020-2029
Figure 35: Switzerland Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (US$ Million), 2020-2029
Figure 36: Switzerland Diabetes Devices and Therapeutics Market Share by Combination Drugs (%), 2020-2029
Figure 37: Switzerland Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (US$ Million), 2020-2029
Figure 38: Switzerland Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (US$ Million), 2020-2029
Figure 39: Switzerland Diabetes Devices and Therapeutics Market Share by Route of Administration (%), 2020-2029
Figure 40: Switzerland Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (US$ Million), 2020-2029
Figure 41: Switzerland Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (US$ Million), 2020-2029
Figure 42: Switzerland Diabetes Devices and Therapeutics Market Size by Others, by Value (US$ Million), 2020-2029
Figure 43: Switzerland Diabetes Devices and Therapeutics Market Share by Type of Diabetes (%), 2020-2029
Figure 44: Switzerland Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (US$ Million), 2020-2029
Figure 45: Switzerland Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (US$ Million), 2020-2029
Figure 46: Switzerland Diabetes Devices and Therapeutics Market Share by Distribution Channels (%), 2020-2029
Figure 47: Switzerland Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (US$ Million), 2020-2029
Figure 48: Switzerland Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (US$ Million), 2020-2029
Figure 49: Switzerland Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (US$ Million), 2020-2029
Figure 50: Switzerland Diabetes Devices and Therapeutics Market Share by End User (%), 2020-2029
Figure 51: Switzerland Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (US$ Million), 2020-2029
Figure 52: Switzerland Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (US$ Million), 2020-2029
Figure 53: Switzerland Diabetes Devices and Therapeutics Market Size by Homecare, by Value (US$ Million), 2020-2029

Table Information

Report AttributeDetails
No. of Pages50
PublishedMarch 2025
Forecast Period2025 - 2029
Estimated Market Value ( USD ) in 2025 $ 1.28 Billion
Forecasted Market Value ( USD ) by 2029 $ 1.82 Billion
Compound Annual Growth Rate9.2%
Regions CoveredSwitzerland

Related Topics

Related Reports

Diabetes Devices Market Size, Share & Trends Analysis Report by Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Diabetes Devices Market Size, Share & Trends Analysis Report by Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 195 Pages
  • Global
From
Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update - Product Image

Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update

  • Report
  • 1400 Pages
  • Global
From
Europe Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update - Product Image

Europe Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update

  • Report
  • 980 Pages
  • Europe
From
Diabetes Insulin Pumps Market - Global Forecast 2025-2030 - Product Image

Diabetes Insulin Pumps Market - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Type 1 Diabetes Drug Market - Global Forecast 2025-2032 - Product Image

Type 1 Diabetes Drug Market - Global Forecast 2025-2032

  • Report
  • 198 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.